Stride Soles Disrupts $6.7 Billion Orthotics Market with Direct-to-Consumer, Tech-Enabled Custom Insoles

As demand for orthopedic insoles accelerates, Stride Soles eliminates barriers to clinical-grade orthotics with a digital-first, sustainable model

NEW YORK, July 22, 2025 /PRNewswire/ -- With orthopedic insole demand projected to more than double from $3.2 billion in 2025 to $6.7 billion by 2035, Stride Soles is redefining access to clinical-grade custom orthotics. By eliminating traditional barriers of cost, access, and production time, Stride delivers precision-fit orthotics through a direct-to-consumer platform.

Frustrated by the high cost and slow delivery of clinic-made orthotics, CEO Greg Gerla partnered with physician Dr. Zac Cartun, MD, in 2021 to create a better way. Working with German podiatrists and biomechanical experts, they developed Stride's process: a podiatrist-designed intake quiz, smartphone 3D foot scan, and gait analysis — all without a clinic visit.

"As interest in foot health and injury prevention rises, people want orthotics that actively support performance and long-term mobility," said Dr. Dietmar Walter, Head of Podiatry at Stride Soles. "Stride delivers clinical-grade orthotics direct to consumers, with no compromise on precision."

Market analysts cite aging populations, sports participation, chronic foot conditions, and demand for sustainable solutions as key growth drivers. Investor confidence in the insole category is also surging: Coats Group recently announced its $770 million acquisition of insole-maker OrthoLite, underscoring both the market's trajectory and the demand for scalable, sustainable solutions.

Stride pairs German engineering with eco-conscious 3D printing, reducing production waste by 97% while delivering a precision fit. Made from durable TPU bioplastic and finished with vegan leather, Stride orthotics are designed to provide biomechanical support and enhance foot function — supporting healthier movement patterns and promoting long-term mobility.

According to Stride's medical team, key benefits associated with clinical-grade orthotics may include:

• Improved alignment and posture through stabilized foot mechanics
• Reduced foot discomfort tied to conditions like plantar fasciitis, flat feet, or overpronation
• Enhanced shock absorption and pressure distribution, potentially reducing joint strain
• Increased comfort and endurance during daily activity and sports
• Encouragement of natural arch strength over time, supporting injury prevention

By combining precision craftsmanship with digital innovation, Stride aims to give consumers proactive access to clinical-grade foot support — without the traditional clinic markup.

About Stride Soles
Founded by Greg Gerla, Dr. Zac Cartun, MD, and a team of German podiatrists, Stride Soles delivers custom, medical-grade orthotics worldwide through digital innovation and clinical expertise. Learn more at www.stridesoles.com.

Media Contact:
Meryl Haley Communications
[email protected] 
www.mh-comms.com

SOURCE Stride Soles